Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system
European Heart Journal: Acute Cardiovascular Care · 2024
DOI: 10.1093/ehjacc/zuae019 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2024. Verfasst von Katharina Mohr und 22 weiteren Autor:innen. Beteiligte Einrichtung: Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germ…. Hauptthemen laut MEDLINE: Pulmonary Embolism. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, University Medical Centre Mainz.
Abstract (Originalsprache)
Aims
Catheter-directed treatment (CDT) of acute pulmonary embolism (PE) is entering a growth phase in Europe following a steady increase in the USA in the past decade, but the potential economic impact on European healthcare systems remains unknown. Methods and results We built two statistical models for the monthly trend of proportion of CDT among patients with severe (intermediate- or high-risk) PE in the USA. The conservative model was based on admission data from the National Inpatient Sample (NIS) 2016–20 and the model reflecting increasing access to advanced treatment from the PERT™ national quality assurance database registry 2018–21. By applying these models to the forecast of annual PE-related hospitalizations in Germany, we calculated the annual number of severe PE cases and the expected increase in CDT use for the period 2025–30. The NIS-based model yielded a slow increase, reaching 3.1% (95% confidence interval 3.0–3.2%) among all hospitalizations with PE in 2030; in the PERT-based model, increase would be steeper, reaching 8.7% (8.3–9.2%). Based on current reimbursement rates, we estimated an increase of annual costs for PE-related hospitalizations in Germany ranging from 15.3 to 49.8 million euros by 2030. This calculation does not account for potential cost savings, including those from reduced length of hospital stay.
Conclusion
Our approach and results, which may be adapted to other European healthcare systems, provide a benchmark for healthcare costs expected to result from CDT. Data from ongoing trials on clinical benefits and cost savings are needed to determine cost-effectiveness and inform reimbursement decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany.
- Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
- Division of Cardiothoracic Surgery, Emory University Hospital, Atlanta, GA, USA.
- Wiesbaden Business School, RheinMain University of Applied Sciences, Wiesbaden, Germany.
- Division of Hematology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
- Division of Interventional Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
ORCID-Profile: Katharina Mohr, Thomas Neusius, Rachel P Rosovsky, John M Moriarty, Kenneth Rosenfield, Christina Abele, Ioannis T Farmakis, Karsten Keller, Stefano Barco, Richard N Channick, Jay S Giri, Thomas M Todoran, Lukas Hobohm, Stavros V Konstantinides, Luca Valerio, Eric A Secemsky
Förderung
- NHLBI NIH HHS
- University Medical Centre Mainz
Zitieren
APA
Mohr, K., Keeling, B., Kaier, K., Neusius, T., Rosovsky, R. P., Moriarty, J. M., Rosenfield, K., Abele, C., Farmakis, I. T., Keller, K., Barco, S., Channick, R. N., Giri, J. S., Lookstein, R. A., Todoran, T. M., Christodoulou, K. C., Hobohm, L., Lanno, M., Reed, J., …, & Secemsky, E. A. (2024). Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuae019
Vancouver
Mohr K, Keeling B, Kaier K, Neusius T, Rosovsky RP, Moriarty JM, et al. Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system. European Heart Journal: Acute Cardiovascular Care. 2024. doi:10.1093/ehjacc/zuae019
BibTeX
@article{Mohr2024,
author = {Mohr, Katharina and Keeling, Brent and Kaier, Klaus and Neusius, Thomas and Rosovsky, Rachel P and Moriarty, John M and Rosenfield, Kenneth and Abele, Christina and Farmakis, Ioannis T and Keller, Karsten and Barco, Stefano and Channick, Richard N and Giri, Jay S and Lookstein, Robert A and Todoran, Thomas M and Christodoulou, Konstantinos C and Hobohm, Lukas and Lanno, Michelle and Reed, Jamie and Binder, Harald and Konstantinides, Stavros V and Valerio, Luca and Secemsky, Eric A},
title = {Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2024},
doi = {10.1093/ehjacc/zuae019}
}
EUVIMED